As pulmonary arterial hypertension ( PAH ) is associated with significant morbidity and mortality , particularly among patients with right ventricular ( RV ) dysfunction , we aimed to determine the impact of therapy to reduce pulmonary vascular resistance ( PVR ) on RV and LV deformation in PAH .